NLRC4 and breast cancer: Activated NLRC4 leading to IL‐1β signalling has been reported to contribute to pathology and angiogenesis in obese mice with breast cancer via adipocyte‐mediated vascular endothelial growth factor A (VEGFA) expression [17].